10 mg and 5 mg delayed release granules in HPMC capsules clinical trials

AN EXPLORATORY, MULTICENTER, RANDOMIZED,DOUBLE BLIND STUDY OF CLINICAL OUTCOMES,TOLERABILITY, AND SAFETY OF 2 DOSES OF ORAL PANTOPRAZOLE IN PEDIATRIC PARTICIPANTS AGED 1 TO 11 YEARS AND 12 TO 17 YEARS WHO REQUIRE MAINTENANCE THERAPY FOR HEALED EROSIVE ESOPHAGITIS

This study is testing a medication called pantoprazole in children aged 1 to 17. It aims to see if different doses can keep a healed food pipe (oesophagus) from getting sore again, specifically in children with a past condition called erosive oesophagitis.